Literature DB >> 22431224

Insights from comprehensive multiple receptor docking to HDAC8.

Michael Brunsteiner1, Pavel A Petukhov.   

Abstract

A systematic investigation of the available crystal structures of HDAC8 and of the influence of different receptor structures and docking protocols is presented. The study shows that the open conformation of HDAC8 may be preferred by ligands with flexible surface binding groups, as such a conformation allows the ligands to minimize their exposure to solvent upon binding. This observation allowed us to rationalize the excellent potency of pyrazole-based inhibitors compared to that of isoxazole-based inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431224      PMCID: PMC3565472          DOI: 10.1007/s00894-011-1297-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  54 in total

1.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

2.  A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum.

Authors:  Yufeng Chen; Miriam Lopez-Sanchez; Doris N Savoy; Daniel D Billadeau; Geoffrey S Dow; Alan P Kozikowski
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

3.  Incorporating protein flexibility into docking and structure-based drug design.

Authors:  Xavier Barril; Xavier Fradera
Journal:  Expert Opin Drug Discov       Date:  2006-09       Impact factor: 6.098

4.  Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion.

Authors:  Stephanie L Gantt; Samuel G Gattis; Carol A Fierke
Journal:  Biochemistry       Date:  2006-05-16       Impact factor: 3.162

5.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

6.  Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors.

Authors:  Hwangseo Park; Sangyoub Lee
Journal:  J Comput Aided Mol Des       Date:  2004-06       Impact factor: 3.686

7.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

8.  Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.

Authors:  Hao Tang; Xiang S Wang; Xi-Ping Huang; Bryan L Roth; Kyle V Butler; Alan P Kozikowski; Mira Jung; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

9.  Identification of a minimal subset of receptor conformations for improved multiple conformation docking and two-step scoring.

Authors:  Sukjoon Yoon; William J Welsh
Journal:  J Chem Inf Comput Sci       Date:  2004 Jan-Feb

10.  Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies.

Authors:  Rino Ragno; Silvia Simeoni; Dante Rotili; Antonella Caroli; Giorgia Botta; Gerald Brosch; Silvio Massa; Antonello Mai
Journal:  Eur J Med Chem       Date:  2007-05-27       Impact factor: 6.514

View more
  5 in total

1.  Photoreactive "nanorulers" detect a novel conformation of full length HDAC3-SMRT complex in solution.

Authors:  Hazem Abdelkarim; Michael Brunsteiner; Raghupathi Neelarapu; He Bai; Antonett Madriaga; Richard B van Breemen; Sylvie Y Blond; Vadim Gaponenko; Pavel A Petukhov
Journal:  ACS Chem Biol       Date:  2013-10-02       Impact factor: 5.100

2.  Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors.

Authors:  Taha Y Taha; Shaimaa M Aboukhatwa; Rachel C Knopp; Naohiko Ikegaki; Hazem Abdelkarim; Jayaprakash Neerasa; Yunlong Lu; Raghupathi Neelarapu; Thomas W Hanigan; Gregory R J Thatcher; Pavel A Petukhov
Journal:  ACS Med Chem Lett       Date:  2017-08-01       Impact factor: 4.345

3.  Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose.

Authors:  Aditya Sudheer Vaidya; Raghupathi Neelarapu; Antonett Madriaga; He Bai; Emma Mendonca; Hazem Abdelkarim; Richard B van Breemen; Sylvie Y Blond; Pavel A Petukhov
Journal:  Bioorg Med Chem Lett       Date:  2012-09-07       Impact factor: 2.823

4.  Structurally Diverse Histone Deacetylase Photoreactive Probes: Design, Synthesis, and Photolabeling Studies in Live Cells and Tissue.

Authors:  Shaimaa M Aboukhatwa; Thomas W Hanigan; Taha Y Taha; Jayaprakash Neerasa; Rajeev Ranjan; Eman E El-Bastawissy; Mohamed A Elkersh; Tarek F El-Moselhy; Jonna Frasor; Nadim Mahmud; Alan McLachlan; Pavel A Petukhov
Journal:  ChemMedChem       Date:  2019-04-10       Impact factor: 3.540

5.  Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped Inhibitors.

Authors:  Niklas Jänsch; Kim Leoni Lang; Franz-Josef Meyer-Almes
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.